Curs BNR — 13.11.2026 EUR 5,3498 USD 4,8428 GBP 6,4023

ANTIBIOTICE IASI

78 articole · RSS

SIF Oltenia Buys 780,000 Shares In Antibiotice Iasi For RON395,000
Capital Market

SIF Oltenia Buys 780,000 Shares In Antibiotice Iasi For RON395,000

Romanian regional investment fund SIF Oltenia (SIF 5.RO) bought on December 14, a stake of 780,000 shares in state-run drugmaker Antibiotice Iasi (ATB.RO), at a unitary price of RON0.56 per...

Ecaterina Craciun · 15.12.2016 · 14:26 · 1 min
Antibiotice Iasi Ceases Payment Of 2012 Dividends As Of November
Companies

Antibiotice Iasi Ceases Payment Of 2012 Dividends As Of November

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will cease the payment of dividends from 2012 profit as of November 1, 2016, the company said in a statement Monday.

Gabriela Stan · 17.10.2016 · 16:43 · 1 min
Ioan Nani, Antibiotice Iasi: Clawback Tax Became A Drawback For Drugmakers
Health

Ioan Nani, Antibiotice Iasi: Clawback Tax Became A Drawback For Drugmakers

The medicine industry is more and more affected by the clawback tax, as the tax currently accounts for approximately 30% of the value added of a drugmaker, which will soon lead to the collap...

Gabriela Stan · 02.10.2016 · 14:08 · 1 min
Companies

Antibiotice Iasi Sales Up 9% In January-June

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported sales of RON143.8 million in January-June 2016, up 9% from the year-earlier period.

Gabriela Stan · 01.08.2016 · 11:15 · 1 min
Antibiotice Iasi 1Q Profit Up 18% To RON7.1M
Health

Antibiotice Iasi 1Q Profit Up 18% To RON7.1M

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a profit of RON7.1 million in January-March 2016, up 18% from the year-earlier period.

Ecaterina Craciun · 17.05.2016 · 13:10 · 1 min
Antibiotice Iasi Suspends Pay Of Remaining Dividends For 2011's Profit
Capital Market

Antibiotice Iasi Suspends Pay Of Remaining Dividends For 2011's Profit

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Tuesday said on the Bucharest Stock Exchange it will suspend the payment of the dividends due for 2011 and not cashed by the stockholde...

Roxana Pricop · 16.09.2015 · 14:00 · 1 min
Antibiotice Iasi Extends RON60M Loan Into 2015
Capital Market

Antibiotice Iasi Extends RON60M Loan Into 2015

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will extend by one year its 60 million lei (some EUR13 million) credit line signed with EximBank in July 2013, according to a sharehold...

Florentina Dragu · 26.06.2014 · 17:29 · 1 min
Antibiotice Iasi, Set To Near EUR100M In Revenue In 2016
Health

Antibiotice Iasi, Set To Near EUR100M In Revenue In 2016

Antibiotice Iasi (ATB.RO) plans to boost revenue by stepping up exports and launching new products. The company ranks 11th among the biggest players on the Romanian pharmaceutical market.

Catalina Apostoiu · 01.05.2014 · 22:32 · 2 min
Antibiotice Iasi: Exports Reach 30% Of 2013 Sales
Health

Antibiotice Iasi: Exports Reach 30% Of 2013 Sales

Health Ministry-owned drug producer Antibiotice Iasi (ATB.RO) estimates this year's exports to amount to more than $26 million or 30% of its total sales.

Loredana Frățilă-Cristescu · 29.12.2013 · 00:00 · 1 min